Keratins are predominantly found in epithelial cells and form the intermediate lament (IF) component of the cytoskeleton. Depolymerisation of these laments causes the cell to collapse and become more plastic. We have previously shown that short chain fatty acids may trigger depolymerisation of keratins through altered protein acetylation. Currently, there is no single functional assay for screening of the cytoskeleton. e aim of this study is to develop a high-throughput assay to quantify IF depolymerisation and to apply as a screen for IF-perturbing nutrients and drugs. ree treatments were used in a proof-of-principle study: the anti-fungal drugs griseofulvin and cordycepin (the former is known tosuppress microtubule growth, the latter induces abnormal mitosis by suppressing microtubule dynamics with concequent impact on IF organisation) and sodium butyrate, a histone deacetylase inhibitor which disrupts IF formation in cancer cells via post-translational modi cation of keratins.
Introduction
Intermediate laments (IFs) are found in all cells, with keratins particulary abundant in epithelial cells. ey crosslink to microtubules, actin and myosin by accessory proteins such as laggrin and plectin and bundle into strong arrays [1] . In contrast to micro laments and microtubules, it is not understood how IFs remodel the cytoskeleton. By identifying keratins and keratin-associated protein mutations in disease, an insight can be provided into how they act. IFs confer rigidity to epithelial cells, characterised by high visco-elasticity and exibility [2] . functioning to protect epithelial cells from mechanical and non-mechanical stress [3] . Interfering with the dynamics of IFs leads to a reduced resilience of the epi-thelia to mechanical stress [4] . e highly dynamic keratin network implicates a perpetual cycle of assembly and disassembly commencing with nucleation of keratin particles at the cell periphery into a proto-lament, followed by elongation towards the nucleus to form a stable network. Perinuclear disassembly releases soluble oligers which di use through the cytoplasm and are recycled into new proto laments at the periphery [4] . Intermediate laments are formed from polymerised coiled dimers of Type I smaller acidic Krt 9 to 20 and Type II larger basic Krt 1 to 8 [5] , comprising mainly Krt 8 and Krt 18 in intestinal epithelia). . Keratin regulation occurs through post translational modications (PTMs). Krt 8 has been shown to be acetylated at ve lysine residues: K10, K100, K392, K471 and K482 in HCT116 colon cancer cells [6] . Over-expression of Krt 8 has been implicated in several colorectal pathologies [7] suggesting that keratins may be essential to epithelial homeostasis and altered function may contribute to conditions such as inammatory bowel disease [6] . HCA enables quanti cation of staining intensities by use of computational analysis of images captured by an automated uorescent microscope adapted to read 96 well plates [8] . It is capable of measuring multiple cellular parameters simultaneously on a cell by cell basis and can also be used for semi-quanti cation of antibody staining pro les. e automation of acquisition and analysis means that the technique is high throughput and multi-parametric. We have previously employed HCA to analyse the e ects of short chain fatty acids on Krt 8 acetylation [9] and cytoskeletal structure [8] , demonstrating that butyrate-induced acetylation of Krt 8 is associated with reduced polymerisation of IFs [9] . e benets of HCA include substantial cost savings due to a reduction in the number of hours involved in performing the experiment and smaller amounts of consumables being used. In drug development, HCA streamlines the work load required for validating drugs prior to animal and clinical testing as well as supplementing systems biology [8] .
Currently, there exists no keratin screening tool in a single functional assay. e aim of this study is to establish a viable assay for cytoskeletal staining of intermediate laments, and to establish proof of principle for high throughput development following perturbation with depolymerising agents.
Material and Methods

General Reagents and Solutions
Phosphate-bu ered saline Dulbecco "A" (PBS) solution was supplied by OXoid, Basingstoke, U.K. RPMI1640 Gluta-MAX media was supplemented with 500 units of penicillin/ streptomycin and L-Glutamine 2 mM nal conc (Gibco Life Technologies, Invitrogen, U.K) and 10 % Foetal Bovine Serum (Biosera, East Sussex, U.K). e cell treatments griseofulvin, cordycepin and sodium butyrate were supplied by Sigma-Aldrich, Poole, Dorset, U.K. Cells were stained with mouse monoclonal antibodies to Krt 8 supplied by abcam, Cambridge, U.K and Alexa uor 555 donkey anti mouse antibody and Hoechst 33342 weresupplied by Invitrogen, U.K.
Cell Culture protocol
MCF-7 cells obtained from HPACC were cultured in RPMI media and incubated at 37 °C, 5% CO 2 in humidi ed air. Con uency, viability and cell counts (stained with Trypan Blue, Gibco, Life Technologies, U.K,) were assessed using an optical microscope and haemocytometer ("Improved Neubauer" chamber).
Protocols for High Content Analysis (HCA):
Cell Seeding and Treatment MCF-7 cells were cultured in Black-sided Costar 96-well culture plates (Sigma-Aldrich) at 2.5 x 10 3 cells per 100 µl RPMI media. Plates were incubated at 37 °C for 24 hours to allow cells to adhere, a er which media was replaced with fresh media containing either sodium butyrate treatment at 0, 2.5, 5, 10, 15, 20 mM for 16 hours, n = 20 for initial pilot experiment to optimise staining conditions, griseofulvin in at 0, 2, 5, 10, 20, 50, 100, 150 and 200 µM for 48 hours (n = 3), or cordycepin, (0, 2, 5, 10, 15, 30 and 60 µM for 15 and 30 minutes, n = 3),the latter two containing 0.1% DMSO to aid solubilisation with relevant vehicle only controls.
Optimisation of Staining
Preliminary experiments were undertaken with 20 mM Sodium Butyrate to optimise staining, xing and blocking protocols, as detailed below.Fixative: Cells were xed with either 10 % bu ered formalin (Sigma-Aldrich) for 15 minutes at room temperature, or ice cold methanol (Fisher Scienti c, Loughborough, U.K) for 5 minutes at minus 20 °C , a er which, they were washed twice with 100 µl PBS before a nal addition of 100 µl PBS. Plates were sealed for storage at 4 °C prior to staining.
Blocker: Prior to antibody staining, plates were blocked for non-speci c protein binding with either PBS control or 2% BSA (made up in PBS) for 10 minutes to observe di erences in background staining intensities as well as di erences in texture and uorescence intensity.
Permeabilisation: To facilitate entry into the cell, the antibody was diluted in a detergent or permeabilising agent according to Cellomics' HCA protocols. Mouse monoclonal Krt 8 antibody was diluted at a nal concentration of 0.01 mg/ml in PBS containing 500 µg/ml digitonin, or 1 mg/nl saponin or 0.1% triton X-100. 50 µl of antibody was added to each well and le for 1 hour at room temperature. Wells were washed three times with 100 µl PBS and subsequently stained for 30 minutes at room temperature with 50 µl of 0.005 mg/ml Alexa uor red 555 donkey anti-mouse antibody containing 0.004 mg/ml Hoechst 33342 DNA stain. As before, wells were washed three times with 100 µl PBS, with a nal addition of 100 µl PBS to store the cells in. Plates were sealed and stored at 4 °C prior to image analysis.
HCA Image Analysis and Quanti cation
Analysis was undertaken using a Cellomics Arrayscan II platform which employs a Compartmental Analysis algorithm for measurement of total cytoplasmic uorescence intensity (arbitrary units) [8] . A morphology algorithm enables cell texture intensity measurements (arbitrary units) to be determined, based on the co-occurrence of adjacent pixel intensities. is is derived from the probability of pixels with di erent intensities occurring next to each other. Cooccurence measures how lamentous the cytoskeleton is. A strong healthy protein is visualised as rough laments whereas a broken protein causes laments to become 'mushy' with a smooth, di used appearance,.
is nonlamentousness, consistent with cellular depolymerisation, is characterised byuniform staining, providing a low texture intensity measurement .Highly varied intensities indicate structural staining, providing a larger value for this parameter.
e contrast measurement re ects the strength of occurences of pixels of di ering intensity being adjacent to each other, whereby the greater the di erence, the stronger the weighting. Other parameters measured included cell count (per well), bre spot count and bre spot total area (arbitrary units).
e method for bre-spot size analysis identi es which pixels belong to spots or bres by evaluating the change in intensity over space within the object. A background correction is applied automatically to di erentiate between spots and bres, and intra-cellular noise [10] .
Results and Discussion
Optimisation of Intermediate Filaments Staining for HCA
Both methanol and formalin xation were used to assess the viability of developing a dual assay for keratin/tubulin or keratin/actin staining. Methanol is traditionally employed in immuno uoresence experiments as the xative of choice for microtubules and intermediate laments since cross-linking reagents such as formaldehyde, though good at preserving cell structure, may reduce antigenicity of components [11] . Preliminary experiments of cells treated with sodium butyrateshowed that methanol xation provided consistently sharper images (Fig 1, panel 2 ) compared to 10% formalin (Fig 1, panel 1) . Additionally, cells treated with increasing concentrations of butyrate and xed with methanol remained consistent in number compared to those xed with formalin which showed a reduction in cell count, P <0.005 (Fig 1D, expressed as percent of control population) , hence methanol was used as a xative of choice.
An initial 30 minute blocking step with BSA (2 %) was included to block non-speci c binding of the Krt 8 antibody (Fig 1A -1C, panels 1 and 2 ). Visual inspection of acquired images showed no major di erence between PBS control or BSA blocked cells. No signi cant di erence was observed in texture intensity measurement when comparing unblocked (PBS) cells to 2% BSA blocked cells using a students paired T test (PBS 1.07 ± 0.62 vs 2% BSA 1.09 ± 0.63, P = 0.86, arbitrary units) or Krt 8 mean total uorescence intensity (PBS 3.6 x 10 6 ± 2 x 10 6 vs 2% BSA 3.3 x 10 6 ± 1.9 x 10 6 , P = 0.44, arbitrary units). Consequently this step was omitted in future experiments enabling mechanical manipulations to be kept to a minimum, thus ensuring the quality of nal images would remain uncompromised.
Intracellular epitopes require permeabilising to allow the antibody to access the inside of the cell to detect the protein of interest. Low concentrations of Triton X-100 has been shown to remove some cortical uorescence from mitotic cells [12] , where detergent-resistant material was identi ed as non-lamentous keratin aggregates. Drake et al [8] and Khan et al [9] diluted antibodies with a digitonin permeabilising solution in accordance with Cellomics' HCA internal protocols. In preliminary experiments using sodium butyrate, cells stained with Krt 8 antibody at a concentration of 0.01 mg/ml diluted in PBS (Fig 1A) or 0.1 % Triton X-100 did not stain as well as those using the milder membrane solubilisers digitonin (500 µg/ml) and saponin (1 mg/ml), the latter two thought to produce pores su ciently large enough for the antibody to pass through without dissolving the plasma membrane. On closer visual inspection, saponin showed better uniform staining of cellular architecture and was used in subsequent experiments (Fig 1B, 1C ).
Assay validation with intermediate lament disrupting agents.
All cytoskeletal components are co-ordinated -no part acts alone. Drugs a ecting actin, tubulin, or both may also a ect the intermediate lament organising system. Interference of intermediate lament dynamics in human disease and transgenic mice leads to reduced resilience of the epithelia to mechanical stress [4] . Gordon et al [13] demonstrated disruption of microtubules, but not actin, could lead to intermediate lament reorganisation. E ects of the cytostatic drugs cytochalasin B, D and β lumicochicine and vinblastine on microtubules and micro laments showed an induction of keratin rearrangement in Hela cells [14] . SW13 cells treated with latrunculin B (destroys actin) and nocozadole (depolymerises microtubules) completely blocked keratin motility, implying that this function relies both on intact actin micro laments and microtubules [15] .
Following an extensive knowledgebase review, griseofulvin was identi ed as a potent trigger of intermediate lament breakdown. A metabolic product of Penicillium griseofulvium, griseofulvin is absorbed by the GI tract into body uids and tissues eventually reaching keratinised skin structures [16] . Griseofulvin-damaged mouse livers incorporated with 32 P orthophosphate showed alterations in keratin lament architecture where a shi towards acidic isoforms of Type I keratins was thought to be due to hyperphosphorylation [17] , demonstrating the role PTMs play in IF homeostasis in vivo. is C-mitotic anti-fungal drug induces G2-M arrest / apoptosis in several cell lines, selectively killing cancer cells yet sparing healthy cells [18] . MCF-7 cells treated with 15 -90 µM griseofulvin for 24 -48 hours stabilised microtubule dynamics by reducing the length and rate of growing and shortening phases [19] . For this reason, griseofulvin was chosen as an IF perturbing tool in the current studies to evaluate its e ect on cytoskeletal depolymerisation. e adenosine analogue Cordycepin, deriving from culture ltrates of Cordyceps militaris and Aspergillus nidulans, was the rst naturally occurring nucleotide (3'-deoxyadenosine) to be isolated [20] . Zeive et al [21] demonstrated rapid collapse of intermediate laments in keratinocytes treated with cordycepin where microtubules were depolymerised to small stumpy asters. MCF-7 cells treated with cordycepin suggested the initial e ect on cell cycle was due to changes in polyadenylate polymerase activity prior to apoptosis [22] . OEC-M1 cells treated with cordycepin and stained with annexin V for early apoptosis appeared rounded up a er 3 hours but were still adherent to the matrix (longer treatments of up to 48h re ected an apoptotic trend thought to be cordycepin inducing G2/M cell arrest [23] ). Low doses have been shown to decrease cell proliferation whereas high doses a ect cell adhesion and indirectly reduce protein synthesis [24] . Inhibition of MCF-7 cell proliferation by cordycepin has been attributed to autophagy rather than apoptosis [25] . As a result of these ndings, cordycepin was identi ed as a potential candidate for IF disruption in this proof of principle study.
e short chain fatty acid sodium butyrate was chosen for preliminary experiments. e most biologically potent of the SCFAs, it has previously been shown to strongly e ect cellular depolymerisation prior to apoptosis [8] , making it an ideal candidate for optisation of staining protocols. It is naturally produced in the colon by fermentation of dietary bre and is a fuel for colonocytes. Colon carcinoma cell proliferation is inhibited via early G1 phase arrest at concentrations of 1 -5 mM sodium butyrate with no impact on cell viability (proliferation is stimulated in normal colonic epithelium) [26] and induces apoptosis in vitro. Hela cells incubated with 1 -5mM butyrate increased histone acetylation by inhibiting histone deacetylase, paralleling changes seen in H3 phosphorylation [27] . Multiple sites of acetylation in Krt 8 and Krt 18 have been identi ed by our group [8] in HCT116 and CaCo2 cells, where butyrate-induced acetylation of Krt 8 was associated with breakdown of the cytoskeleton via reduced polymerisation of IFs [9] . Immuno blots of intermediate laments isolated from butyrate treated HCT116 cells treated further con rm Krt 8 is acetylated, thus conveying the HDACi status of butyrate as a post translational modi er of cytokeratins [6] .
Proof of Concept as a high-throughput assay
Assay e cacy was established and validated by using the proof of principle Z' calculation to acertainwhether the response was su cient enough to warrant further investigation. Acceptable Z' values fall between 0.5 and 1.0, with perfect assay values approaching 1.0 [28] .
MCF-7 cells treated with 100 µM griseofulvin for 48 hours (n = 3) show altered morphology, becoming multi-nucleated when compared to controls (Fig 2A (1) and (2) ). is is re ected in the measurements of lamentousness (Fig 2A (5-7) arbitrary units) where signi cant decreases in texture intensity (4.4 ± 0.47 vs 2.2 ± 0.03, P<0.05), bre spot count (16.4 ± 0.64 vs 10.7 ± 2.1, P<0.01), bre spot total area (1368 ± 51 vs 555 ± 23, P=0.0005) as well as cell count per well were observed (646 ± 186 vs 288 ± 103, P<0.05, Fig 2A (3) ) A signicant increase in Krt 8 mean total uorescence intensity (202632 ± 60337 vs 97262 ± 23343, P<0.05, arbitrary units, Fig 2A (4) ) was observed when comparing treated cells to controls. Acceptable Z'values ( Fig 2B) were obtained for bre spot count (0.95) and bre spot total area (0.73), demonstrating suitability for high throughput development (Fig 2B) .
Two further treatments a ecting intermediate laments; sodium butyrate and cordycepin, are assayable using the described methods.
Following 16 hours treatment with 20 mM sodium butyrate (n = 20), cells showed similar morphology, with contrast between the cytoplasm and the nuclear staining more pronounced when compared to untreated cells. 20 mM butyrate (Fig 3A (3-5) ) signi cantly reduced texture intensity (3.06 ± 0.38 vs 2.41 ± 0.39, P< 0.001), bre spot count (5.78 ±0.85 vs 5.23 ± 0.6, P<0.02) and bre spot total area (144.8 ± 11.8 vs 134.9 ± 8.3, P<0.005, all arbitrary units, paired students T test). A non-signi cant reduction in cell count per well was observed when comparing control to treated cells (670 ± 171 vs 627 ± 50, Fig 3A (1) ) emphasising the suitability of butyrate as a depolymerising agent without causing a disruption in cell number. As with griseofulvin, an increase in mean total Krt 8 uorescence intensity was observed, though this was not signi cant (161983 ± 51982 vs 165148 ± 42567, arbitrary units, Fig 3A (2) ). Higher concentrations may be required to cause su cient depolymerisation prior to cell death.
Visual inspection of cells treated for 15 minutes with 60 µM cordycepin (n = 3) con rmed that keratin bres do retract to form a peri-nuclear ring, as observed by its e ects on microtubules (Zieve et al [4] ). is may explain the signicant decrease in mean total Krt 8 uorescence intensity (arbitrary units, Fig 3B (2) ) from 385698 ± 9862 vs 353452 ± 3297, P<0.05, in contrast to the increase observed with griseofulvin, P<0.05, and sodium butyrate (not signi cant). As with griseofulvin and sodium butyrate, texture intensity was also signi cantly decreased (Fig 3B (3), 2 .39 ± 0.18 vs 1.57 ± 0.07, P<0.05, arbitrary units) indicating depolymerisation and a loss of lamentouness when compared to controls, though no signi cant di erences were observed for measurements of bre spot count (Fig 3B (4) , 10.39 ± 1.15 vs 11.23 ± 1.98), bre spot total area (Fig 3B (5) , 733 ± 13 vs 653 ± 70, arbitrary units) and cell count per well (Fig 3B (1) , 124 ± 12 vs 145 ± 60) when comparing controls to treated cells. is could possibly be attributed to the shorter treatment time with cordycepin (15 minutes) compared to griseofulvin (48 hours) and sodium butyrate (16 hours) leading to a lower overall cell population by the end of the experiment (higher cordycepin doses around 200µM have been found to a ect cell adhesion [26] ).
e results indicate that a functional assay for the direct assessment of IF-perturbing drugs has been developed, optimised by the directed and informed combination of existing technologies. Keratins are emerging as potentially important targets in colorectal pathologies [7] and therefore may become the target for development of new therapeutics. As such, assays need to be in place for such applications. General cytoskeletal biology indicates that the various cytoskeletons are interlinked and collapse of one may impact upon another [4, 14, 15, 16] .
is assay has the potential to be combined with a chemical stain (phalloidin) or antibody from another species to form a duplex or triplex assay for integrity of the microtubular, micro lamentous and IF cytoskeletons and thereby determine hierarchicality of impact of chemotherapeutics at the cellular level.
